Citi Downgrades Integra LifeSciences (IART) to Sell, Sees Revenue Impact of $60M and EPS Impact of $0.35
Tweet Send to a Friend
(Updated - May 23, 2023 9:02 AM EDT)
Citi analyst Joanne Wuensch downgraded Integra LifeSciences (NASDAQ: IART) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst Joanne Wuensch downgraded Integra LifeSciences (NASDAQ: IART) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
